Sunday, May 28, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder

SAN FRANCISCO - A federal judge dismissed claims that Medivation and its officers misrepresented how a treatment for Alzheimer's disease performed in clinical trials.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading...